| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |